( July 31, 2026, 3:15 PM EDT) -- NEW ORLEANS — Stating that the U.S. Supreme Court has an “unshakeable interest in resolving issues surrounding mifepristone” and pointing out recent comments by Acting U.S. Attorney General Todd Blanche, who testified before Congress that a U.S. Food and Drug Administration’s 2023 decision that removed the in-person dispensing requirement for the drug was “‘wrong,’ and [that] Louisiana’s laws are ‘really what’s being violated here,’” Louisiana and a woman who claims that she was forced to take one of two drugs used to induce early termination of pregnancy tell the Fifth Circuit U.S. Court of Appeals in a reply brief to stay that decision....